Basics Amneal Pharmaceuticals, Inc. IPO Date: January 1, 1900 Sector: Healthcare Industry: Biotech Market Cap: $2.64B Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 2.51% Avg Daily Range (30 D): $0.11 | 1.40% Avg Daily Range (90 D): $0.13 | 1.66% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): 1.29M Avg Daily Volume (90 D): 1.49M Trade Size Avg Trade Size (Sh.): 152 Avg Trade Size (Sh.) (30 D): 98 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 1,665 Avg Inst. Trade: $1.55M Avg Inst. Trade (30 D): $2.4M Avg Inst. Trade (90 D): $2.21M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.67M Avg Closing Trade (30 D): $2.76M Avg Closing Trade (90 D): $2.51M Avg Closing Volume: 203.26K     News Jun 25, 2025 @ 12:00 PM Amneal Highlights Positive Topline Results from Co... Source: N/A Jun 12, 2025 @ 12:00 PM Amneal Receives U.S. FDA Approval for Prednisolone... Source: Amneal Pharmaceuticals, Inc. Jun 9, 2025 @ 8:56 AM Selective Estrogen Receptor Modulators Market Rese... Source: Researchandmarkets.Com Jun 6, 2025 @ 5:31 PM Goldman Sachs Bullish On Branded Drug Upside At Te... Source: Vandana Singh Jun 5, 2025 @ 5:00 PM Global Antidote Market to Cross the USD 4 Billion ... Source: Delveinsight Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.04 $.04 $-.1 Diluted EPS $-.04 $.04 $-.1 Revenue $ 2.83B $ 695.42M $ 730.52M Gross Profit $ 1.04B $ 255.89M $ 262.87M Net Income / Loss $ 32.42M $ 24.62M $ -20.74M Operating Income / Loss $ 360.42M $ 100.35M $ 75.79M Cost of Revenue $ 1.79B $ 439.53M $ 467.65M Net Cash Flow $ 16.78M $ -50.03M $ 40.08M PE Ratio     Splits Aug 26, 2013:   1:25